Loading...
XNYS
TPVG
Market cap229mUSD
Oct 27, Last price  
5.68USD
1D
0.18%
1Q
-19.77%
Jan 2017
-51.78%
IPO
-63.09%
Name

Triplepoint Venture Growth BDC Corp

Chart & Performance

D1W1MN
P/E
7.15
P/S
3.22
EPS
0.79
Div Yield, %
19.37%
Shrs. gr., 5y
9.49%
Rev. gr., 5y
12.11%
Revenues
71m
-48.22%
29,941,20022,538,00015,591,00024,640,00041,526,00040,201,00042,002,00083,365,000119,424,000137,490,00071,187,000
Net income
32m
P
17,149,20015,521,00011,126,00019,227,00036,562,00031,758,00035,307,00076,558,000-46,831,000-39,821,00032,046,000
CFO
153m
+44.06%
-286,122,0002,146,000-93,686,00025,102,000-17,821,000-187,540,00060,582,000-144,679,000-100,889,000106,148,000152,921,000
Dividend
Sep 16, 20240.3 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
IPO date
Mar 06, 2014
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT